Vanguard Group Portfolio holdings
AUM
$6.9T
Turnover
4.07%
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$6.18T
AUM Growth
+$647B
(+12%)
Cap. Flow
+$78.1B
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
28.81%
Holding
4,383
New
103
Increased
2,425
Reduced
1,410
Closed
108
Avg Time Held
8.1
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.95B |
| 2 |
NVIDIA
NVDA
|
+$4.97B |
| 3 |
Capital One
COF
|
+$4.5B |
| 4 |
Amazon
AMZN
|
+$3.45B |
| 5 |
Flutter Entertainment
FLUT
|
+$3.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Discover Financial Services
DFS
|
+$5.32B |
| 2 |
Intra-Cellular Therapies Inc.
ITCI
|
+$1.26B |
| 3 |
Amphenol
APH
|
+$1.18B |
| 4 |
Welltower
WELL
|
+$987M |
| 5 |
US Steel
X
|
+$825M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.14% |
| 2 | Financials | 14% |
| 3 | Consumer Discretionary | 10.14% |
| 4 | Healthcare | 9.38% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3776
Ovid Therapeutics
OVID
$428M
| $870K | ﹤0.01% |
2,636,115
-472,666
| -15% | -$142K |
2017 Q2
32 quarters
|
|
3777
Radware
RDWR
$1.21B
| $867K | ﹤0.01% |
29,463
| – | – |
2016 Q2
36 quarters
|
|
3778
CVD Equipment Corp
CVV
$27.2M
| $866K | ﹤0.01% |
290,698
-2,531
| -0.9% | -$7.47K |
2013 Q2
48 quarters
|
|
3779
DELISTED
IGM Biosciences
IGMS
| $859K | ﹤0.01% |
767,154
-108,415
| -12% | -$132K |
2019 Q3
23 quarters
|
|
|
BTLN
3780
Brightline Interactive
BTLN
$13.8M
| $853K | ﹤0.01% |
78,375
+4,255
| +6% | +$43.5K |
2021 Q4
14 quarters
|
|
3781
Intellinetics
INLX
$21.1M
| $852K | ﹤0.01% |
68,198
+36,788
| +117% | +$475K |
2023 Q4
6 quarters
|
|
3782
Dyadic International
DYAI
$16.4M
| $852K | ﹤0.01% |
860,661
+46,318
| +6% | +$50.8K |
2019 Q2
24 quarters
|
|
|
SOHO
3783
DELISTED
Sotherly Hotels
SOHO
| $845K | ﹤0.01% |
886,621
+196,634
| +28% | +$156K |
2013 Q2
48 quarters
|
|
3784
Aris Mining
ARIS
$3.35B
| $842K | ﹤0.01% |
125,059
+5,664
| +5% | +$33.6K |
2024 Q3
3 quarters
|
|
3785
Enerflex
EFXT
$3.15B
| $836K | ﹤0.01% |
105,919
-6,361
| -6% | -$45.5K |
2022 Q4
10 quarters
|
|
3786
Bright Minds Biosciences
DRUG
$500M
| $835K | ﹤0.01% |
+31,983
| New | +$959K |
2025 Q2
0 quarters
|
|
3787
Avalo Therapeutics
AVTX
$635M
| $833K | ﹤0.01% |
166,941
| – | – |
2024 Q2
4 quarters
|
|
3788
Laser Photonics
LASE
$45.8M
| $833K | ﹤0.01% |
309,555
+4,840
| +2% | +$12.7K |
2023 Q1
9 quarters
|
|
3789
Comscore
SCOR
$58M
| $833K | ﹤0.01% |
172,729
| – | – |
2018 Q3
27 quarters
|
|
3790
DELISTED
Elevation Oncology
ELEV
| $828K | ﹤0.01% |
2,256,690
-328,530
| -13% | -$110K |
2021 Q2
16 quarters
|
|
3791
Vanguard Long-Term Treasury ETF
VGLT
$10.6B
| $824K | ﹤0.01% |
14,684
+4,299
| +41% | +$238K |
2024 Q3
3 quarters
|
|
3792
Harvard Bioscience
HBIO
$37.1M
| $823K | ﹤0.01% |
185,389
-28,486
| -13% | -$119K |
2013 Q2
48 quarters
|
|
3793
Allied Gold Corp
AAUC
$2.7B
| $822K | ﹤0.01% |
+61,203
| New | +$865K |
2025 Q2
0 quarters
|
|
3794
GameSquare
GAME
$38.1M
| $820K | ﹤0.01% |
117,959
+86,512
| +275% | +$507K |
2024 Q1
5 quarters
|
|
|
YARW
3795
Yarrow Bioscience
YARW
$159M
| $819K | ﹤0.01% |
9,926
+413
| +4% | +$26.8K |
2018 Q1
29 quarters
|
|
|
LIMN
3796
Liminatus Pharma
LIMN
$4.37M
| $819K | ﹤0.01% |
+1,468
| New | +$824K |
2025 Q2
0 quarters
|
|
3797
Kornit Digital
KRNT
$733M
| $817K | ﹤0.01% |
41,052
| – | – |
2017 Q3
31 quarters
|
|
3798
Big Sky Industrial
BSIN
$74M
| $817K | ﹤0.01% |
583,643
| – | – |
2020 Q4
18 quarters
|
|
3799
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.43B
| $816K | ﹤0.01% |
6,606
-65
| -1% | -$7.65K |
2023 Q1
9 quarters
|
|
3800
Passage Bio
PASG
$11.8M
| $816K | ﹤0.01% |
102,028
-1,549
| -1% | -$11.3K |
2020 Q1
21 quarters
|
|
Similar funds
CWM
FAF
BGIM
CIM
UOC
Vanguard Group's Q2 2025 Portfolio in Review
As of Q2 2025, Vanguard Group held 4,383 positions worth $6.18T, up 12% from $5.53T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 4.8%. Vanguard Group opened 103 new positions and exited 108, leaving the 4,383-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q2 2025 buy was Amrize Ltd: 21,350,540 shares worth $1.07B.
- Vanguard Group added most to Microsoft in Q2 2025, an estimated $5.95B increase.
- Vanguard Group's biggest Q2 2025 reduction was Amphenol, cutting an estimated $1.18B.
- Vanguard Group fully exited Discover Financial Services in Q2 2025, selling an estimated $5.32B.
- Vanguard Group's ten largest holdings make up 29% of its $6.18T portfolio in Q2 2025.
- Vanguard Group opened 103 new positions and closed 108 in Q2 2025.
- Vanguard Group's portfolio value rose 12% quarter-over-quarter to $6.18T.
Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.